TVGNW

distress 6/10 · elevated risk

$0.05-10%today-13% from 52w high

tevogen.com18 employeesFounded 2020Warren, NJ

Revenue

pre-revenue

Liquidity

$1M

Runway

0.1 yrs

Shares 1y

-98%

Price & events

+9.9% over 6M

CatalystRating changeDilutionFinancingdashed = today

-9.8%

-13.5%

+40.4%

—

+9.9%

All

Overview

Market Cap: $199.32K
Volume: 827.06K
52 Week Range: $0.03 – $0.06
Total Shares: 4.19M
Float Shares: 1.07M
RVOL: 16.07x
Beta: 0.22

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 1

2025-01-28partnershipReceived $2M initial grant (up to $10M total) from KRHP LLC for T cell therapeutics and AI expansion.SEC 8-K

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 4,187,505 · 7 offerings/1y · 0 PIPEs

2026-06-26424B3offering
2026-06-25EFFECTshelf_effective
2026-06-12S-3shelf_registration
2026-03-25424B3offering
2026-03-04424B3offering
2026-02-26424B3offering
2025-11-14424B3offering

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified